AI turns old diabetes drug Halicin into a potent weapon against superbugs
Researchers found that Halicin, an AI-identified drug, effectively inhibited most multidrug-resistant bacteria except Pseudomonas aeruginosa. The study highlights Halicin’s broad-spectrum
AI-driven discovery of Halicin offers a breakthrough in combating antibiotic-resistant bacteria, addressing one of modern medicine’s most urgent challenges. About Careers Internship MedBlog Contact us
Dubbed halicin—after the thinking machine in “2001: A Space Odyssey”—the compound was shown to be incredibly effective against strains of Clostridium difficile, Acinetobacter baumannii and
The AI’s first breakthrough in 2020 was the identification of an old diabetes drug called halicin that was able to kill several different strains of multidrug-resistant bacteria in mice.
(Source: www.tiktok.com)
(Source: www.pexels.com)
(Source: aiimpacts.org)
Comments
Post a Comment